Literature DB >> 21179634

Long-acting risperidone in the treatment of schizophrenia: an evidence-based approach.

Maju Mathews1, Babatunde Adetunji, Jamal Mahmud, Vinu George, Mathews Thomas, Sunil Joseph.   

Abstract

Entities:  

Year:  2005        PMID： 21179634      PMCID： PMC3004719     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


× No keyword cloud information.
  16 in total

1.  Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

Authors:  Stephen R Marder; Robert Conley; Larry Ereshefsky; John M Kane; Martin S Turner
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

Review 2.  Compliance with antipsychotic treatment.

Authors:  M Oehl; M Hummer; W W Fleischhacker
Journal:  Acta Psychiatr Scand Suppl       Date:  2000

3.  Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.

Authors:  S Kapur; R B Zipursky; G Remington
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

4.  Healthcare resource utilization during 1-year treatment with long-acting, injectable risperidone.

Authors:  A Leal; D Rosillon; A Mehnert; M Jarema; G Remington
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-11       Impact factor: 2.890

5.  Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.

Authors:  David M Taylor; Corina L Young; Shubhra Mace; Maxine X Patel
Journal:  J Clin Psychiatry       Date:  2004-08       Impact factor: 4.384

6.  Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone.

Authors:  Robert A Lasser; Cynthia A Bossie; Georges M Gharabawi; Martin Turner
Journal:  Eur Psychiatry       Date:  2004-06       Impact factor: 5.361

Review 7.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

8.  Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen.

Authors:  L Ereshefsky; S R Saklad; T Tran-Johnson; G Toney; R C Lyman; C M Davis
Journal:  Psychopharmacol Bull       Date:  1990

Review 9.  Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.

Authors:  S Grant; A Fitton
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

Review 10.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546
View more
  1 in total

1.  Need for heat stabilization of long-acting risperidone.

Authors:  Anjali Varma
Journal:  Psychiatry (Edgmont)       Date:  2005-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.